Myomo, Inc. financial data

Symbol
MYO on NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
137 Portland Street, 4 Th Floor, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 268 % -5.11%
Quick Ratio 39.5 % +24.7%
Debt-to-equity 67.2 % +27.9%
Return On Equity -45.3 % +46.5%
Return On Assets -27.1 % +51.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 34.4M shares +20.7%
Common Stock, Shares, Outstanding 34.4M shares +26.7%
Entity Public Float 67.2M USD +606%
Common Stock, Value, Issued 3.44K USD +26.7%
Weighted Average Number of Shares Outstanding, Basic 37.8M shares +28%
Weighted Average Number of Shares Outstanding, Diluted 37.8M shares +28%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 32.6M USD +69.2%
Cost of Revenue 9.37M USD +54.6%
Research and Development Expense 4.77M USD +81%
Selling and Marketing Expense 12.2M USD +35.3%
General and Administrative Expense 12.4M USD +27.2%
Operating Income (Loss) -6.21M USD +24.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.82M USD +27.2%
Income Tax Expense (Benefit) 366K USD +134%
Net Income (Loss) Attributable to Parent -6.18M USD +24.1%
Earnings Per Share, Basic -0.16 USD/shares +42.9%
Earnings Per Share, Diluted -0.16 USD/shares +42.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 24.4M USD +255%
Cash, Cash Equivalents, and Short-term Investments 24.9M USD
Accounts Receivable, after Allowance for Credit Loss, Current 3.83M USD +60.5%
Inventory, Net 3.17M USD +75.5%
Assets, Current 32.8M USD +140%
Property, Plant and Equipment, Net 1.33M USD +657%
Operating Lease, Right-of-Use Asset 7.58M USD +1043%
Other Assets, Noncurrent 164K USD +80.2%
Assets 42.2M USD +190%
Liabilities, Current 10.2M USD +85.7%
Operating Lease, Liability, Noncurrent 7.36M USD +6290%
Liabilities 17.5M USD +213%
Accumulated Other Comprehensive Income (Loss), Net of Tax -14.4K USD -117%
Retained Earnings (Accumulated Deficit) -103M USD -6.38%
Stockholders' Equity Attributable to Parent 24.7M USD +175%
Liabilities and Equity 42.2M USD +190%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.25M USD -78.7%
Net Cash Provided by (Used in) Financing Activities 5.36M USD -7.11%
Net Cash Provided by (Used in) Investing Activities -3.54M USD -7758%
Common Stock, Shares Authorized 65M shares 0%
Common Stock, Shares, Issued 34.4M shares +26.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.44M USD -137%
Deferred Tax Assets, Valuation Allowance 16.9M USD +17.6%
Deferred Tax Assets, Gross 18.8M USD +30.6%
Operating Lease, Liability 8.11M USD +1248%
Depreciation 29.7K USD -39%
Payments to Acquire Property, Plant, and Equipment 59.8K USD +32.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -6.28M USD +22.5%
Lessee, Operating Lease, Liability, to be Paid 11.5M USD +1584%
Property, Plant and Equipment, Gross 2.32M USD +141%
Operating Lease, Liability, Current 748K USD +53.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.17M USD +1036%
Lessee, Operating Lease, Liability, to be Paid, Year One 680K USD +17.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure -64.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.36M USD +4116%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.52M USD
Deferred Tax Assets, Operating Loss Carryforwards 12.3M USD +4.74%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.58M USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.87M USD
Share-based Payment Arrangement, Expense 874K USD -21.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%